Sionna Therapeutics (SION) announced the appointment of Caroline Stark Beer, MBA, as its Chief Business Officer. She was most recently CBO at Jnana Therapeutics until Jnana’s sale to Otsuka Pharmaceutical.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SION:
- Sionna Therapeutics initiated with a Buy at JonesResearch
- Buy Rating for Sionna Therapeutics: Innovative Cystic Fibrosis Treatments with Promising Clinical Trials
- Short Report: Frontier Group short positioning continues gaining altitude
- Sionna Therapeutics initiated with a Sector Perform at RBC Capital
- Sionna Therapeutics initiated with a Strong Buy at Raymond James